OPSYH — Opsy Holding AB Share News
0.000.00%
Last trade - 00:00- SEK109.83m
- SEK108.97m
- SEK6.69m
Brief: Wntresearch Gets About SEK 25.4 Million Before Issue Costs
Brief: Wntresearch: New Data Shows Foxy-5 In Colon Cancer Reduces Number Of Cancer Stem Cells
Brief: Wntresearch Q4 Pre-Tax Loss Widens To SEK 11.6 Million
Brief: Wntresearch Initiates New Research Project And Submits Patent Application
Brief: WntResearch Enters Into Agreement With SAGA Diagnostics Regarding Kroma Technology
Brief: Wntresearch AB Announces Positive Results In Interaction Study With Foxy-5 And Immunotherapy
Brief: Wntresearch Q2 Net Loss Falls To SEK 3.7 Mln
Brief: Wntresearch Enters Agreement With Biovica International
Brief: Wntresearch Enters Agreement With SMS Oncology
Brief: Wntresearch: Positive Outcome In An In Vitro Interaction Study With Foxy-5 And Chemotherapy
Brief: WntResearch Q1 Net Loss Narrows To SEK 3.6 Million
Brief: WntResearch Q4 Pretax Loss Widens To Sek 6.9 Mln
Brief: Wntresearch Delays Start Of Phase 2 Study With Foxy-5
Brief: Wntresearch Appoints New CEO
Brief: WntResearch proposes rights issue of shares and units
Brief: Wntresearch CEO steps down
Brief: Wntresearch Q2 pre-tax loss widens to SEK 11.8 mln
Brief: WntResearch: positive results from clinical study with drug candidate Foxy-5
Brief: WntResearch announces positive results from clinical study with drug candidate Foxy-5